Archive for ArcherDX

ArcherDX Receives Breakthrough Device Designation to Detect NTRK Gene Fusions

May 19, 2020

Bayer and ArcherDX Announce Global Collaboration to Develop Next-Generation Sequencing-based Companion Diagnostic for VITRAKVI

May 15, 2020

ArcherDX and UCL Present New Minimal Residual Disease Surveillance Data

April 30, 2020

ArcherDX Wins Breakthrough Nod for Personalized Cancer Monitoring Tech

January 16, 2020

ArcherDX Personalized Cancer Monitoring Technology Designated by FDA as Breakthrough Device

January 14, 2020

ArcherDX expands co-marketing, in vitro diagnostics partnerships with Illumina

January 13, 2020